Logo - springer
Slogan - springer

Biomedical Sciences - Cancer Research | Cellular Oncology

Cellular Oncology

Cellular Oncology

The official journal of the International Society for Cellular Oncology

Editor-in-Chief: Ad Geurts van Kessel

ISSN: 2211-3428 (print version)
ISSN: 2211-3436 (electronic version)

Journal no. 13402

$99.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 6 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Learn more about the metrics of this journal Logo ISCO
The Official Journal of the International Society for Cellular Oncology
    • Focuses on translational research
    • Addresses the conversion of cell biology to clinical applications

Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.

In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.

Related subjects » Biomedical Sciences - Cancer Research - Oncology & Hematology - Pathology

Impact Factor: 3.786 (2016) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index, Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, Biological Abstracts, BIOSIS, Current Abstracts, Current Contents/ Life Sciences, Current Contents/Clinical Medicine, EBSCO Academic Search, EBSCO Advanced Placement Source, EBSCO Biomedical Reference Collection, EBSCO STM Source, EBSCO TOC Premier, Index to Scienctific & Technical Proceedings, OCLC, SCImago, Sociedad Iberoamericana de Informacion Cientifica (SIIC) Databases, Summon by ProQuest

Read this Journal on Springerlink

For authors and editors


  • Journal Citation Reports®
    2016 Impact Factor
  • 3.786
  • Aims and Scope

    Aims and Scope

    Close

    Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions. A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients. Cellular Oncology publishes Original Articles, Reviews, Short Communications, Commentaries, and Letters to the Editor.                    

    "In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations."

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for authors
  • Author Academy: Training for Authors

Services for the Journal

Alerts for this journal

 

Get the table of contents of every new issue published in Cellular Oncology.